Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Isopropylhydroxylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropylhydroxylamine SCHEMBL26630700 | 1.00 | — | — | |
| Isopropylhydroxylamine SCHEMBL64261 | 0.95 | — | — | |
| Isopropylhydroxylamine SCHEMBL3417601 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL27563355 | 0.76 | — | — | |
| Oxalic Acid SCHEMBL10472230 | 0.76 | TP53 (0.39) | — | |
| Hydrochloric Acid SCHEMBL5591553 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL6950357 | 0.73 | — | — | |
| Isopropylhydroxylamine SCHEMBL8194593 | 0.71 | — | — | |
| SCHEMBL590442 | 0.70 | — | — | |
| SCHEMBL15061881 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805686-B | Oil-extended styrene butadiene rubber and preparation method thereof | 中国石油天然气股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-114805686-A | Oil-extended styrene-butadiene rubber and preparation method thereof | 中国石油天然气股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-111909313-B | In-situ reinforced styrene-butadiene latex as well as preparation method and application thereof | 山东京博中聚新材料有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-111909313-A | In-situ enhanced styrene-butadiene latex as well as preparation method and application thereof | 山东京博中聚新材料有限公司 | 2020-11-10 | — | — | CN | claimed |
| CN-111560096-A | Preparation method of styrene butadiene rubber | 中国石油天然气股份有限公司 | 2020-08-21 | — | — | CN | claimed |
| US-5904823-A | Methods of purifying hydroxylamine solutions and converting hydroxylamine salts to hydroxylamine | SACHEM, INC. (US) | 1999-05-18 | — | — | US | claimed |
| EP-0870532-A2 | Methods of purifying hydroxylamine solutions and converting hydroxylamine salts to hydroxylamine | Sachem, Inc. (US) | 1998-10-14 | — | — | EP | claimed |
| EP-0677535-A1 | Shortstopping of free radical polymerizations | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1995-10-18 | — | — | EP | claimed |
| US-5384372-A | TERMINATING EMULSION POLYMERIZATION BY ADDING ISOPROPYLHYDROXYLAMINE OR SALT THEREOF | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1995-01-24 | — | — | US | claimed |
| EP-0616973-A1 | Process for removing excess acid from acidic hydroxylamine salt solution | Sachem, Inc. (US) | 1994-09-28 | — | — | EP | claimed |
| US-5281311-A | Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts | SACHEM, INC. (US) | 1994-01-25 | — | — | US | claimed |
| EP-0577100-A1 | Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts | SACHEM, INC. (US) | 1994-01-05 | — | — | EP | claimed |
| US-5259934-A | Process for removing acid from a hydroxylamine salt solution containing excess acid | SACHEM, INC. (US) | 1993-11-09 | — | — | US | claimed |
| WO-2026098672-A1 | BIAZACYCLOALKANE MENIN-MLL PROTEIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 赛诺哈勃药业（成都）有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-122010910-A | Biazacycloalkane Menin-MLL protein inhibitor, pharmaceutical composition and application thereof | 赛诺哈勃药业（成都）有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-3970849-B1 | POLYMERS AND DNA COPOLYMER COATINGS | ILLUMINA CAMBRIDGE LTD (GB) | 2025-12-17 | — | — | EP | disclosed |
| EP-0199153-A2 | Lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1986-10-29 | — | — | EP | disclosed |
| US-4608390-A | ANTIINFLAMMORY, ANTIALLERGENS, ASTHMA, PSORIASIS, ARTHRITIS | ABBOTT LABORATORIES (US) | 1986-08-26 | — | — | US | disclosed |
| US-3987053-A | ANTIMICROBIAL | GRUPPO LEPETIT S.P.A. (IT) | 1976-10-19 | — | — | US | disclosed |
| US-3954789-A | 2-Nitroimidazole derivatives | GRUPPO LEPETIT S.P.A. (IT) | 1976-05-04 | — | — | US | disclosed |